// App-Quantinova.ai

2105-286 : THE COMPARATIVE EFFECTIVENESS OF BIVALIRUDIN AND PLATELET GLYCOPROTEIN IIBIIIA INHIBITORS AMONG PATIENTS UNDERGOING CONTEMPORARY PRIMARY PCI: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR COLLABORATIVE (BMC2)

Researchers

Presenter

  • Hitinder S. Gurm

Principal Investigators

  • Milan Seth

  • Mohamad Kenaan

  • Stanley Chetcuti

  • Simon Dixon

  • David Share

  • Paul Grossman

  • Mauro Moscucci

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Folate Hydrolase 1

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved